Sickle

Results: 876



#Item
601Phase 1 Clinical Trial Of The Candidate Anti-Sickling Agent Aes-103 In Adults With Sickle Cell Anemia Gregory J. Kato, MD, Marlene Peters Lawrence, RN, Laurel G. Mendelsohn, BS, Rehan Saiyed, BS, Xunde Wang, PhD, Anna K.

Phase 1 Clinical Trial Of The Candidate Anti-Sickling Agent Aes-103 In Adults With Sickle Cell Anemia Gregory J. Kato, MD, Marlene Peters Lawrence, RN, Laurel G. Mendelsohn, BS, Rehan Saiyed, BS, Xunde Wang, PhD, Anna K.

Add to Reading List

Source URL: aesrx.com

Language: English - Date: 2013-12-19 11:36:38
602Preparticipation Physical Evaluation HISTORY Name__________________________________Sex______Age______Date of Birth__________________ Address________________________________________________________________________________

Preparticipation Physical Evaluation HISTORY Name__________________________________Sex______Age______Date of Birth__________________ Address________________________________________________________________________________

Add to Reading List

Source URL: www.dakotacollege.edu

Language: English - Date: 2014-04-14 13:25:49
603Anti-sickling Agent Aes-103 Protects Red Blood Cells From Hemolysis by Mechanical Agitation Kevin Y. Wang, Leah Pedoeim, Laurel Mendelsohn, Jim Nichols, Xunde Wang, and Gregory J. Kato Hematology Branch, National Heart L

Anti-sickling Agent Aes-103 Protects Red Blood Cells From Hemolysis by Mechanical Agitation Kevin Y. Wang, Leah Pedoeim, Laurel Mendelsohn, Jim Nichols, Xunde Wang, and Gregory J. Kato Hematology Branch, National Heart L

Add to Reading List

Source URL: aesrx.com

Language: English - Date: 2013-12-19 11:36:31
604research paper 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells, Osheiza Abdulmalik1,* Martin K. Safo2,*

research paper 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells, Osheiza Abdulmalik1,* Martin K. Safo2,*

Add to Reading List

Source URL: aesrx.com

Language: English - Date: 2013-09-10 12:18:02
605

PDF Document

Add to Reading List

Source URL: alabamaadministrativecode.state.al.us

Language: English - Date: 2012-12-24 13:06:47
606Request for Applications[removed]: New York State Sickle Cell Services Program - Transition Program for Young Adults to Adult Medical Care

Request for Applications[removed]: New York State Sickle Cell Services Program - Transition Program for Young Adults to Adult Medical Care

Add to Reading List

Source URL: www.health.ny.gov

Language: English - Date: 2012-09-26 16:37:15
607

PDF Document

Add to Reading List

Source URL: alabamaadministrativecode.state.al.us

Language: English - Date: 2012-12-24 13:06:47
608* A  splenia or splenic dysfunction (splenectomy, sickle cell disease, coeliac syndrome); chronic renal, heart, lung, liver disease, diabetes mellitus, complement deficiency, immunosuppressive conditions; CSF leak, coc

* A  splenia or splenic dysfunction (splenectomy, sickle cell disease, coeliac syndrome); chronic renal, heart, lung, liver disease, diabetes mellitus, complement deficiency, immunosuppressive conditions; CSF leak, coc

Add to Reading List

Source URL: hse.ie

    609

    PDF Document

    Add to Reading List

    Source URL: www.bcshguidelines.com

    Language: English - Date: 2012-07-23 10:22:06
    610Adult Pneumococcal Vaccination Guide for Health Care Professionals Two pneumococcal vaccines are approved by NACI for use in adults (19 years and older): a 23valent pneumococcal polysaccharide vaccine (PPSV23) and a 13-v

    Adult Pneumococcal Vaccination Guide for Health Care Professionals Two pneumococcal vaccines are approved by NACI for use in adults (19 years and older): a 23valent pneumococcal polysaccharide vaccine (PPSV23) and a 13-v

    Add to Reading List

    Source URL: novascotia.ca

    Language: English - Date: 2014-04-01 09:02:45